Publications by authors named "Giuseppe Di Gesu"

Article Synopsis
  • MUC1 oncoprotein is often overexpressed in various thyroid cancers and contributes to their resistance to chemotherapy.
  • Research indicates that MUC1-C, a specific subunit of MUC1, is found in high levels in thyroid cancer cells and affects mitochondrial function, preventing cell death.
  • Targeting MUC1-C through RNA interference has been shown to increase sensitivity of aggressive anaplastic thyroid cancer cells to chemotherapy, suggesting it could be a promising therapeutic target.
View Article and Find Full Text PDF

Although CD95 and its ligand are expressed in thyroid cancer, the tumor cell mass does not seem to be affected by such expression. We have recently shown that thyroid carcinomas produce interleukin (IL)-4 and IL-10, which promote resistance to chemotherapy through the up-regulation of Bcl-xL. Here, we show that freshly purified thyroid cancer cells were completely refractory to CD95-induced apoptosis despite the consistent expression of Fas-associated death domain and caspase-8.

View Article and Find Full Text PDF

Background: Chronic constipation in children can be caused by cows' milk intolerance (CMI), but its pathogenesis is unknown.

Aims: To evaluate the histology and manometry pattern in patients with food intolerance-related constipation.

Patients And Methods: Thirty-six consecutive children with chronic constipation were enrolled.

View Article and Find Full Text PDF

We investigated the mechanisms responsible for the widespread refractoriness to chemotherapeutic drugs observed in thyroid cancers. We show that malignant epithelial cells from papillary, follicular, and anaplastic thyroid carcinomas express high levels of Bcl-2 and Bcl-xL. Exogenous expression of either Bcl-2 or Bcl-xL in normal thyrocytes was sufficient to prevent chemotherapeutic drug-induced cytotoxicity.

View Article and Find Full Text PDF